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Background Information 
Interferon gamma (IFNy) is a potent growth lnhlb~tory cytoklne It brnds 
to a speclflc receptor on target cell surface and trlggers a slgnal transductton 
pathway through whlch changes In the expression of speclflc gene systems are 
effected. Although many studies have shown the growth inhlbltory effect of 
IFNy, ~ t s  mechanism of actlon remalns poorly understood. In the present study 
different human cell l~nes were used in order to gain lnformat~on on the nature 
of IFNy-medlated inhibrtlon of proliferation 
Earller studles from thls laboratory using unsynchronized cultures of 
WlSH cell line showed that IFNy inhiblts growth by effectrng cell cycle arrest at 
G11S boundary In the present study, the molecular detalls of the nature of cell 
cycle arrest In asynchronous WlSH cells were worked out Further, 
experiments were performed w~th synchronized population of WlSH cells to 
characterize the actlon of lFNy In greater detall Parallel stud~es were done 
using the primary colon carclnoma cell line, SW480, and its metastasized form, 
SW620 to examine their response to the IFNy-med~ated growth ~nhibltion. The 
study was undertaken with the objective to gain insight Into the molecular 
characterlstlcs of the response of the non-transformed fetal eplthel~ai cell l~ne 
WlSH and the colon cancer cell llnes SW620 and SW480 to the growth- 
lnhlbltot-y actlon of IFNy 
Summary 
IFN gamma (IFNy) br~ngs about ~nh~bit~on of growth of asynchronous 
WlSH cells In a revers~ble manner deta~n~ng the cells at the G1IS boundary 
Treatment of cells w~th the cytok~ne for a durat~on of 72 hrs led to a severe 
reduct~on In the protetn as well as act~v~ty level of cycl~n dependent k~nase 2 
(CDK2), the k~nase that regulates the GIIS trans~t~on I  the cell cycle Deta~led 
analyses of the factors contr~but~ng to th~s reduced CDK2 actlv~ty revealed an 
overall reduct~on In the prote~n and/or act~v~ty of majority of the regulators of 
CDK2 The prote~n level of the cyclin partner for CDK2 dur~ng the GIIS 
transition, Cycl~n E was found to reduce drast~cally by the end of 72 hrs of 
treatment with the IFN In add~t~on, the CDC25A phosphatase that removes the 
rnact~vat~ng phosphates from C D K ~  molecule was also reduced In ~ ts  prote~n 
levels This reduct~on was reflected In ~ t s  act~vlty as well, ascerta~ned by an In 
v~tro phosphatase assay for untreated and IFNy-treated WlSH cells 
Treatment of asynchronous WlSH cells w~th IFNy d ~ d  not affect the 
prote~n levels of the k~nase present In CDK2 activat~ng k~nase CAK 11, namely 
CDK7 but led to severely reduced levels of ~ t s  cycl~n partner Cycl~n H and 
therefore poss~bly In the k~nase activity of CAK II as well The low CDK2 
act~v~ty In IFNy-treated WlSH cells was not found to be assoc~ated w~th a 
concom~tant Increase In the levels of ~ t s  ~nh~b~tory molecules p21 and p27, 
wh~ch also showed reduced prote~n levels Thus, both the class of regulators of 
CDK2 act~v~ty, the actrvators as well as the rnh~b~tors were ~nh~blted upon 
treatment of asynchronous WlSH cells w~th the IFN 
The effect of IFN treatment was also perceived by other cell cycle 
proteins not d~rectly ~nvolved In regulat~ng the activity of CDK2 such as the 
Cycl~n DlCDK4 complex Prote~n levels of Cyclin D were reduced to barely 
detectable levels by the end of 72 hrs of IFN treatment. Th~s would poss~bly 
lead to a reduct~on In the CDK4 k~nase act~v~ty although CDK4 prote~n level 
rema~ned unaffected The ret~noblastoma prote~n pRb, another regulator of the 
G11S trans~t~on, showed overall reduct~on In its prote~n levels w~thout any 
preferent~al increase In its hypophosphorylated act~ve form. The reduced CDK2 
actlvlty was therefore a result of the down regulatlon of most ~ t s  regulatory 
molecules The rnhlbrtlon of other cell cycle protelns was a result of thew 
turnover durlng the cell cycle arrest of WlSH cells upon treatment wlth the iFN 
The nature of prollferatlon arrest In WlSH cells was studled In greater 
detalls to ascertain the confinement of the actlon polnt of IFN to any speclflc 
phase In the cell cycle The questlon was addressed by treatlng synchronlzed 
populatlon of WlSH cells with IFNy Two synchronrzatlon agents, IFNa and 
Mlmoslne, wlth entlrely different modes of actlon, were used to synchronize 
WlSH cells and the reverslblllty of arrest as also the re-entry of the cells Into 
the cell cycle w~thout any lag was conflrmed Cell prollferatlon assays wlth 
IFNa- or Mlmoslne- synchronrzed WlSH cells treated wlth IFNy conflrmed that 
the actlon polnt of lFNy lay wlthln the G I  phase of the cell cycle Molecular 
studles of synchronlzed WlSH cells treated wlth lFNy revealed that the 
lnhlbltlon of synchronlzed WlSH cells d ~ d  not ~nvolve the down regulatlon of 
elther the proteln or the actlvlty of CDK2 Also, nelther the cyclln partner of 
CDK2 at the G1/S, namely Cyclln E, nor the CDK2 actrvat~ng phosphatase was 
affected at the level of expression or actlvlty Contrary to the observatron wlth 
asynchronous WlSH populatlon, IFN treatment of synchronlzed WlSH cells 
lead to an Increase In CDK2 actlvlty, lndlcatlve of a role for CDK2 In IFN- 
medlated cell cycle arrest In WlSH cells 
Parallel studres were carr~ed out uslng colon carcinoma cell llnes 
SW620 and SW480 to study thew response to the antlprollferatlve actlon of 
lFNy The metastasized SW620 cell llne responded to the growth lnhlbltory 
actlon of the IFN In a concentrat~on-dependent manner SW620 cells were 
resistant to hlgher concentratlons of the cytoklne (200 U and above), showlng 
a strmulatory effect on growth wlth Increase in concentration of the IFN lFNy at 
concentratlons 150 U and below was found to growth ~nhlblt he SW620 cells 
At the molecular level, the IFNy-medlated lnhlb~tlon of growth of SW620 cells 
was not characterized by reduction In the actlvlty of CDK2, whlch was slmllar to 
the proflie of CDK2 In synchronlzed WlSH cells exposed to the cytoklne. Other 
regulatory molecules of CDK2 such as Cyclin E or CDC25A were also not 
affected by IFN treatment of SW620 cells at low concentrations Comparative 
molecular studres with SW620 cells treated wrth high concentratrons of the IFN 
showed absence of any down regulat~on of CDK2 actlv~ty On the contrary, 
CDK2 act~v~ty was found to increase upon treatment of SW620 cells with the 
non-inhrb~tory concentratlon of the cytok~ne Response of other cell cycle 
proterns studied d ~ d  not reveal any specrf~c pattern to ~nd~cate he reason 
behlnd rnhrbrtlon of growth of SW620 cell with low IFN concentratlon and the 
st~rnulat~on of growth of SW620 cells w~th ~gh  concentratlons of the cytokrne 
SW480, the pr~mary colon cancer cell line cont~nued to remaln resrstant 
to the growth lnhlbrtory action of IFNy ~rrespectrve of the concentratron of the 
cytokine used There was no effect on the act~vity of CDK2 in IFNy-treated 
SW480 cells Detailed study of the varlous cell cycle molecules was not found 
to lndlcate any specif~c reason behrnd the resrstance of SW480 cells to the 
growth ~nhibrtory act~on of IFNy 
